Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
38,929,456
-
Share change
-
-831
-
Total reported value
-
$11,325,506,269
-
Put/Call ratio
-
106%
-
Price per share
-
$290.99
-
Number of holders
-
397
-
Value change
-
+$28,066,563
-
Number of buys
-
188
-
Number of sells
-
190
Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q1 2018
As of 31 Mar 2018,
ABIOMED INC - COMMON STOCK (ABMD) was held by
397 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,929,456 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BROWN CAPITAL MANAGEMENT LLC, Palo Alto Investors LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Bank of New York Mellon Corp, and Winslow Capital Management, LLC.
This page lists
397
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.